Literature DB >> 25464830

Vpr overcomes macrophage-specific restriction of HIV-1 Env expression and virion production.

Michael Mashiba1, David R Collins2, Valeri H Terry3, Kathleen L Collins4.   

Abstract

The HIV-1 accessory protein Vpr enhances infection of primary macrophages through unknown mechanisms. Recent studies demonstrated that Vpr interactions with the cellular DCAF1-DDB1-CUL4 E3 ubiquitin ligase complex limit activation of innate immunity and interferon (IFN) induction. We describe a restriction mechanism that targets the HIV-1 envelope protein Env, but is overcome by Vpr and its interaction with DCAF1. This restriction is active in the absence of Vpr in HIV-1-infected primary macrophages and macrophage-epithelial cell heterokaryons, but not epithelial cell lines. HIV-1-infected macrophages lacking Vpr express more IFN following infection, target Env for lysosomal degradation, and produce fewer Env-containing virions. Conversely, Vpr expression reduces IFN induction, rescues Env expression, and enhances virion release. Addition of IFN or silencing DCAF1 reduces the amount of cell-associated Env and virion production in wild-type HIV-1-infected primary macrophages. These findings provide insight into an IFN-stimulated macrophage-specific restriction pathway targeting HIV-1 Env that is counteracted by Vpr.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25464830      PMCID: PMC4269377          DOI: 10.1016/j.chom.2014.10.014

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  46 in total

1.  Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.

Authors:  A Ono; E O Freed
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells.

Authors:  F Rey; M BouHamdan; J M Navarro; I Agostini; K Willetts; M Bouyac; C Tamalet; B Spire; R Vigne; J Sire
Journal:  J Gen Virol       Date:  1998-05       Impact factor: 3.891

3.  Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing.

Authors:  Nadine Laguette; Christelle Brégnard; Pauline Hue; Jihane Basbous; Ahmad Yatim; Marion Larroque; Frank Kirchhoff; Angelos Constantinou; Bijan Sobhian; Monsef Benkirane
Journal:  Cell       Date:  2014-01-09       Impact factor: 41.582

4.  Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein.

Authors:  T M Ross; A E Oran; B R Cullen
Journal:  Curr Biol       Date:  1999-06-17       Impact factor: 10.834

5.  SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates.

Authors:  Hichem Lahouassa; Waaqo Daddacha; Henning Hofmann; Diana Ayinde; Eric C Logue; Loïc Dragin; Nicolin Bloch; Claire Maudet; Matthieu Bertrand; Thomas Gramberg; Gianfranco Pancino; Stéphane Priet; Bruno Canard; Nadine Laguette; Monsef Benkirane; Catherine Transy; Nathaniel R Landau; Baek Kim; Florence Margottin-Goguet
Journal:  Nat Immunol       Date:  2012-02-12       Impact factor: 25.606

6.  The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells.

Authors:  Jason M Norman; Michael Mashiba; Lucy A McNamara; Adewunmi Onafuwa-Nuga; Estelle Chiari-Fort; Wenwen Shen; Kathleen L Collins
Journal:  Nat Immunol       Date:  2011-08-28       Impact factor: 25.606

7.  APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells.

Authors:  Gregory Berger; Stéphanie Durand; Guillaume Fargier; Xuan-Nhi Nguyen; Stéphanie Cordeil; Serge Bouaziz; Delphine Muriaux; Jean-Luc Darlix; Andrea Cimarelli
Journal:  PLoS Pathog       Date:  2011-09-22       Impact factor: 6.823

8.  Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon.

Authors:  Thomas Pertel; Christian Reinhard; Jeremy Luban
Journal:  Retrovirology       Date:  2011-06-22       Impact factor: 4.602

9.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.

Authors:  Kasia Hrecka; Caili Hao; Magda Gierszewska; Selene K Swanson; Malgorzata Kesik-Brodacka; Smita Srivastava; Laurence Florens; Michael P Washburn; Jacek Skowronski
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

Review 10.  HIV-1 accessory proteins adapt cellular adaptors to facilitate immune evasion.

Authors:  David R Collins; Kathleen L Collins
Journal:  PLoS Pathog       Date:  2014-01-23       Impact factor: 6.823

View more
  32 in total

1.  Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells.

Authors:  Ferdinand Roesch; Léa Richard; Réjane Rua; Françoise Porrot; Nicoletta Casartelli; Olivier Schwartz
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

2.  Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.

Authors:  Caitlin M Miller; Hisashi Akiyama; Luis M Agosto; Ann Emery; Chelsea R Ettinger; Ronald I Swanstrom; Andrew J Henderson; Suryaram Gummuluru
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

3.  HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated Neuroinflammation.

Authors:  Manmeet K Mamik; Elizabeth Hui; William G Branton; Brienne A McKenzie; Jesse Chisholm; Eric A Cohen; Christopher Power
Journal:  J Neuroimmune Pharmacol       Date:  2016-10-10       Impact factor: 4.147

4.  A Novel Class of HIV-1 Inhibitors Targeting the Vpr-Induced G2-Arrest in Macrophages by New Yeast- and Cell-Based High-Throughput Screening.

Authors:  Hirotaka Sato; Tomoyuki Murakami; Ryosuke Matsuura; Masako Abe; Seiji Matsuoka; Yoko Yashiroda; Minoru Yoshida; Hirofumi Akari; Yosuke Nagasawa; Masami Takei; Yoko Aida
Journal:  Viruses       Date:  2022-06-16       Impact factor: 5.818

5.  The DDB1-DCAF1-Vpr-UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction.

Authors:  Ying Wu; Xiaohong Zhou; Christopher O Barnes; Maria DeLucia; Aina E Cohen; Angela M Gronenborn; Jinwoo Ahn; Guillermo Calero
Journal:  Nat Struct Mol Biol       Date:  2016-08-29       Impact factor: 15.369

6.  HIV-1 Vpr increases Env expression by preventing Env from endoplasmic reticulum-associated protein degradation (ERAD).

Authors:  Xianfeng Zhang; Tao Zhou; Dylan A Frabutt; Yong-Hui Zheng
Journal:  Virology       Date:  2016-06-23       Impact factor: 3.616

7.  Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages.

Authors:  Jay Lubow; Maria C Virgilio; Madeline Merlino; David R Collins; Michael Mashiba; Brian G Peterson; Zana Lukic; Mark M Painter; Francisco Gomez-Rivera; Valeri Terry; Gretchen Zimmerman; Kathleen L Collins
Journal:  Elife       Date:  2020-03-02       Impact factor: 8.140

8.  HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages.

Authors:  Hichem Lahouassa; Marie-Lise Blondot; Lise Chauveau; Ghina Chougui; Marina Morel; Marjorie Leduc; François Guillonneau; Bertha Cecilia Ramirez; Olivier Schwartz; Florence Margottin-Goguet
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

9.  Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4+ T Lymphocytes.

Authors:  David R Collins; Jay Lubow; Zana Lukic; Michael Mashiba; Kathleen L Collins
Journal:  PLoS Pathog       Date:  2015-07-17       Impact factor: 6.823

10.  Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages.

Authors:  Li Zhao; Shumei Wang; Meng Xu; Yang He; Xiaowei Zhang; Ying Xiong; Hong Sun; Haibo Ding; Wenqing Geng; Hong Shang; Guoxin Liang
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.